Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 15, 2021 - Issue
Submit an article Journal homepage
147
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Pharmacokinetic Study of Frovatriptan Succinate Tablet After Single and Multiple Oral Doses in Chinese Healthy Subjects

Hongquan Zheng1 Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of China;2 School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People’s Republic of ChinaView further author information
,
Yan Xia3 Jiangsu Leeway Biological Technology Co., Ltd, Nanjing, Jiangsu, People’s Republic of ChinaView further author information
,
Shengjun Qu4 CP Pharmaceutical Qingdao Co., Ltd, Qingdao, Shandong, People’s Republic of ChinaORCID Iconhttps://orcid.org/0000-0002-9055-8336View further author information
ORCID Icon,
Lin Fan2 School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People’s Republic of ChinaView further author information
,
Jingjing Zhang1 Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of ChinaView further author information
,
Zhixiang Ma1 Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of ChinaView further author information
,
Yangsheng Chen4 CP Pharmaceutical Qingdao Co., Ltd, Qingdao, Shandong, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Hongwei Fan1 Department of Clinical Pharmacology Lab, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, People’s Republic of China;2 School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 2961-2968 | Published online: 07 Jul 2021

References

  • MarmuraMJ, SilbersteinSD, SchwedtTJ. The acute treatment of migraine in adults: the American headache society evidence assessment of migraine pharmacotherapies. Headache. 2015;55(1):3–20. doi:10.1111/head.1249925600718
  • WorthingtonI, PringsheimT, GawelMJ, et al. Canadian headache society guideline: acute drug therapy for migraine headache. Can J Neurol Sci. 2013;40(5 Suppl 3):S1–s80. doi:10.1017/S0317167100118943
  • OngJJY, De FeliceM. Migraine treatment: current acute medications and their potential mechanisms of action. Neurotherapeutics. 2018;15(2):274–290. doi:10.1007/s13311-017-0592-129235068
  • SanfordM. Frovatriptan: a review of its use in the acute treatment of migraine. CNS Drugs. 2012;26(9):791–811. doi:10.2165/11209380-000000000-0000022900951
  • EversS, SaviL, OmboniS, LisottoC, ZanchinG, PinessiL. Efficacy of frovatriptan as compared to other triptans in migraine with aura. J Headache Pain. 2015;(16):514. doi:10.1186/s10194-015-0514-825916333
  • ElkindAH, MacGregorEA. Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine. Expert Rev Neurother. 2008;8(5):723–736. doi:10.1586/14737175.8.5.72318457529
  • MacGregorEA. A review of frovatriptan for the treatment of menstrual migraine. Int J Womens Health. 2014;6(1):523–535. doi:10.2147/ijwh.S6344424904224
  • Frova. Drugs-professionals-FDA professional drug information; 2021, Available from: https://www.drugs.com/pro/frova.html. Accessed 624, 2021.
  • BuchanP, KeywoodC, WadeA, WardC. Clinical pharmacokinetics of frovatriptan. Headache. 2002;42(s2):54–62. doi:10.1046/j.1526-4610.42.s2.3.x
  • ElkindAH, WadeA, IshkanianG. Pharmacokinetics of frovatriptan in adolescent migraineurs. J Clin Pharmacol. 2004;44(10):1158–1165. doi:10.1177/009127000426804615342617
  • LandiMT, SinhaR, LangNP, KadlubarFF. Human cytochrome P4501A2. IARC Sci Publ. 1999;148:173–195.
  • Ou-YangDS, HuangSL, WangW, et al. Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population. Br J Clin Pharmacol. 2000;49(2):145–151. doi:10.1046/j.1365-2125.2000.00128.x10671909
  • AndersonGD. Gender differences in pharmacological response. Int Rev Neurobiol. 2008;83:1–10. doi:10.1016/s0074-7742(08)00001-918929073
  • YangJ, HeMM, NiuW, et al. Metabolic capabilities of cytochrome P450 enzymes in Chinese liver microsomes compared with those in Caucasian liver microsomes. Br J Clin Pharmacol. 2012;73(2):268–284. doi:10.1111/j.1365-2125.2011.04076.x21815912

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.